Region Västerbotten

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

[18F]PSMA-PET · Oncology
binds to prostate-specific membrane antigen (PSMA) to visualize prostate cancer

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Region Västerbotten portfolio CI brief
Region Västerbotten pipeline updates RSS

Frequently asked questions about Region Västerbotten

What is Region Västerbotten's pipeline?

Region Västerbotten has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include [18F]PSMA-PET.

Sector hub: All tracked pharma companies